In response to the price for one prescription drug increasing by 5,000 percent as its demand for treatment of a common parasite that attacks people with weakened immune systems has grown, some health experts who treat patients with AIDS and cancer have denounced the new cost to treat a condition could be life-threatening. Read More »
The Center for American Progress has put forward a proposal to make changes within Medicare aimed at helping users, including instituting consumer-friendly ratings of the benefits new drugs may have, limiting what patients must pay for new drugs and requiring pharmaceutical companies to disclose how much is actually spent on researching and bringing new drugs to market, the Associated Press said. Read More »
Vraylar proven to be effective in treating both mental health issues during extensive clinical trials. Read More »
The recent approval by the U.S. Food and Drug Administration of Merck’s pediatric EMEND (aprepitant) capsules means that young cancer patients undergoing chemotherapy won’t have to suffer some of the side effects commonly associated with the disease. Read More »
Xerox recently began working with MO HealthNet, Missouri’s state Medicaid division, to tackle the prescription-opioid drug abuse epidemic by using technology that increases the communication between physicians and pharmacists to ensure that opioids are prescribed and used safely. Read More »
Trxade Group, a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, said on Thursday that Paragon Meds, a national pharmaceutical wholesale distributor, has joined Trxade’s trading marketplace as its newest Trxade supplier partner. Read More »
Cardinal Health is offering eHealth's Medicare plan comparison tool and the iMedicare platform to its retail pharmacy customers so they can easily compare Medicare Part D prescription drug plans. The new online offerings arrive ahead of the open enrollment period, which starts in the middle of October and runs through Dec. 7. Read More »
The annual American Pharmacy Association-led Pharmacy Section at the Utah School, which educates pharmacists and student pharmacists on the dangers of addiction, returned to Salt Lake City in June under a new name, the APhA Institute on Alcoholism and Drug Dependencies, after the Utah School's closure last year. Read More »
The National Community Pharmacists Association (NCPA) recently teamed up with Ulta Lab Tests LLC, a consumer-direct lab testing company, to develop an online lab testing platform for pharmacies that choose to participate. The service will be available nationwide. Read More »
In a recent article on DrugChannels.net, Adam Fein, president of Pembroke Consulting and CEO of Pembroke's Drug Channels Institute, examined recent drug-spending forecasts from the Centers for Medicare and Medicaid Services (CMS), including the following predictions: Read More »
On the heels of the introduction in Congress of legislation aimed at controlling rising prescription drug prices, federal prosecutors have launched an investigation into generic price increases of pharmaceuticals. Despite this, Cardinal Health Chief Financial Officer Michael Kaufmann told financial analysts in New York that generic price inflation would continue, even as the rate of increase has eased in recent months. Read More »
A sluggish economy has not damaged the pharmacy business in Iowa, according to an American Pharmacy News analysis. Read More »
Amicus Therapeutics on Tuesday announced that a pre-New Drug Application (NDA) meeting was held with the U.S. Food and Drug Administration (FDA) to discuss the oral, small-molecule pharmacological chaperone migalastat for the treatment of Fabry disease. Read More »
Trial design is in keeping with FDA's newly released draft guidances. Read More »
U.S. Attorney Booth Goodwin said on Tuesday that Trivillian’s Pharmacy, in Kanawha City, West Virginia, was sentenced in federal court in Charleston to three years of probation for federal health care and drug crimes. Read More »
Lion Biotechnologies Inc. on Monday announced it has opened enrollment in a Phase 2 clinical trial of its lead product candidate, LN-144, for the treatment of refractory metastatic melanoma. Read More »
Kite Pharma receives exclusive option to license multiple T cell receptor gene sequences. Read More »
The Centers for Disease Control and Prevention recently released new recommendations advising all nursing homes to improve antibiotic prescribing practices to protect residents from the effects of antibiotic-resistant infections. Read More »
BioBlast Pharma Ltd. on Monday announced it has been granted a U.S. patent for Cabaletta (IV trehalose) titled "Compositions and Methods for Treating Spinocerebellar Ataxia (SCA)." Read More »
Baxalta Incorporated has announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for approval of an investigational 20 percent concentration immunoglobulin subcutaneous treatment. Read More »
Alerts Sign-up
